Creo Medical Group plc announced that following the completion of the all share merger between Cavendish Securities plc (previously named Cenkos Securities plc) and Cavendish Financial plc (previously named finnCap Group plc), as a consequence of internal reorganisation within the Cavendish Group, the Company has changed its Nominated Adviser and Joint Broker from Cavendish Securities plc to Cavendish Capital Markets Limited.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.75 GBX | 0.00% | -0.71% | -24.46% |
Apr. 24 | ActiveOps sales up; Sancus turnover jumps | AN |
Mar. 01 | EARNINGS AND TRADING: Dar Global celebrates "outstanding" year | AN |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.46% | 152M | |
+73.46% | 12.41B | |
-15.61% | 8.23B | |
+3.88% | 6.46B | |
+14.69% | 5.5B | |
+42.58% | 5.1B | |
-19.05% | 4.05B | |
-32.61% | 2.54B | |
-0.74% | 1.99B | |
+10.80% | 1.99B |
- Stock Market
- Equities
- CREO Stock
- News Creo Medical Group PLC
- Creo Medical Group PLC Announces Change of Nominated Adviser and Joint Broker from Cavendish Securities plc to Cavendish Capital Markets Limited